Literature DB >> 21400699

Production of lentiviral vectors in protein-free media.

Hitoshi Kuroda1, Michael P Marino, Robert H Kutner, Jakob Reiser.   

Abstract

The use of lentiviral vectors for transgene delivery in vitro and in vivo for applications in neuroscience, hematology, developmental biology, stem cell biology, and transgenesis has become commonplace. Lentiviral vectors provide an attractive tool for transgene delivery in part because of their ability to incorporate (integrate) into the genomic DNA of target cells with high efficiency, especially in cells that are not actively dividing. In addition, lentiviral vector-mediated transgene )expression can be maintained for long periods of time. In this unit, we describe protocols for lentiviral vector production in protein-free media using polyethylenimine (PEI)-mediated transfection, resulting in consistent lentiviral vector stocks. Such stocks are then concentrated by ultracentrifugation. We also provide reliable QPCR protocols to titrate lentiviral vectors based on vector DNA copies present in genomic DNA extracted from transduced cells. The vector production and titration protocol described here can be completed within 8 days.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400699     DOI: 10.1002/0471143030.cb2608s50

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  9 in total

1.  Analysis of partial recombinants in lentiviral vector preparations.

Authors:  Seraphin Kuate; Michael P Marino; Jakob Reiser
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

2.  A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.

Authors:  M P Marino; M Panigaj; W Ou; J Manirarora; C-H Wei; J Reiser
Journal:  Gene Ther       Date:  2015-01-22       Impact factor: 5.250

3.  Preparation and application of chikungunya pseudovirus containing double reporter genes.

Authors:  Chunyan Su; Kaiyun Ding; Jingwen Xu; Jianchao Wu; Jiansheng Liu; Jiayuan Shen; Hongning Zhou; Hongqi Liu
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

4.  Efficiency and Specificity of Targeted Integration Mediated by the Adeno-Associated Virus Serotype 2 Rep 78 Protein.

Authors:  Pingjuan Li; Michael P Marino; Jizhong Zou; Takele Argaw; Michael T Morreale; Brian J Iaffaldano; Jakob Reiser
Journal:  Hum Gene Ther Methods       Date:  2018-06       Impact factor: 2.396

5.  Murine model for non-invasive imaging to detect and monitor ovarian cancer recurrence.

Authors:  Natalia J Sumi; Eydis Lima; John Pizzonia; Sean P Orton; Vinicius Craveiro; Wonduk Joo; Jennie C Holmberg; Marta Gurrea; Yang Yang-Hartwich; Ayesha Alvero; Gil Mor
Journal:  J Vis Exp       Date:  2014-11-02       Impact factor: 1.355

6.  A fully human inhibitory monoclonal antibody to the Wnt receptor RYK.

Authors:  Michael M Halford; Maria L Macheda; Clare L Parish; Elena A Takano; Stephen Fox; Daniel Layton; Edouard Nice; Steven A Stacker
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

7.  Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.

Authors:  Vinicius Craveiro; Yang Yang-Hartwich; Jennie C Holmberg; Won Duk Joo; Natalia J Sumi; John Pizzonia; Brian Griffin; Sabrina K Gill; Dan-Arin Silasi; Masoud Azodi; Thomas Rutherford; Ayesha B Alvero; Gil Mor
Journal:  Cancer Med       Date:  2013-08-27       Impact factor: 4.452

8.  Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy.

Authors:  Michael Y He; Michael M Halford; Ruofei Liu; James P Roy; Zoe L Grant; Leigh Coultas; Niko Thio; Omer Gilan; Yih-Chih Chan; Mark A Dawson; Marc G Achen; Steven A Stacker
Journal:  Commun Biol       Date:  2021-07-15

9.  A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.

Authors:  Martin Listek; Anja Hönow; Manfred Gossen; Katja Hanack
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.